CPT2, a fatty acid oxidase, was significantly down-regulated in HFD-fed mice, leading to the accumulation of acylcarnitine in hepatocellular carcinoma (HCC) tissues and serum, which synergistically inhibited the oxidation of fatty acids and activated STAT3, jointly promoting the occurrence of HCC 30. Here, STAT3 is linked to hepatocellular carcinoma.